Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gout
Biotech
George Church spinout restructures, considers strategic options
Big-shot academic origin, a star roster of investors and the proximity of a financing round render GRObio’s slip into uncertainty puzzling.
Angus Liu
Mar 13, 2025 2:00pm
GRO Bio gathers $60M series B to take gout therapy into clinic
Jul 19, 2024 9:59am
Selecta narrows focus to gout drug, freezing rest of pipeline
Aug 17, 2023 8:18am
Selecta, Sobi rout gout in phase 3 trials to take on Horizon
Mar 21, 2023 7:40am
Alnylam culls 3 programs, including once-touted nephropathy med
Dec 16, 2022 1:52pm
Innovent pays nearly $100M for China rights to LG Chem gout med
Dec 15, 2022 10:10am
